{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:21:39Z","timestamp":1791390099971,"version":"4.3.3"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The aim of our study was to analyze the use of complementary and alternative medicine (CAM) supplements, identify possible predictors, and analyze and compile potential interactions of CAM supplements with conventional cancer therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included outpatient cancer patients treated at a German university hospital in March or April 2020. Information was obtained from questionnaires and patient records. CAM\u2013drug interactions were identified based on literature research for each active ingredient of the supplements consumed by the patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>37.4% of a total of 115 patients consumed CAM supplements. Potential interactions with conventional cancer treatment were identified in 51.2% of these patients. All types of CAM supplements were revealed to be a potential source for interactions: vitamins, minerals, food and plant extracts, and other processed CAM substances. Younger age (&lt;\u200962\u00a0years) (<jats:italic>p<\/jats:italic>\u2009=\u20090.020, \u03c6c\u2009=\u20090.229) and duration of individual cancer history of more than 1\u00a0year (<jats:italic>p<\/jats:italic>\u2009=\u20090.006, \u03c6c\u2009=\u20090.264) were associated with increased likelihood of CAM supplement use. A wide range of different CAM supplement interactions were reviewed: effects of antioxidants, cytochrome (CYP) interactions, and specific agonistic or antagonistic effects with cancer treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The interaction risks of conventional cancer therapy with over-the-counter CAM supplements seem to be underestimated. Supplements without medical indication, as well as overdoses, should be avoided, especially in cancer patients. To increase patient safety, physicians should address the risks of interactions in physician\u2013patient communication, document the use of CAM supplements in patient records, and check for interactions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-021-03675-7","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T11:11:51Z","timestamp":1625569911000},"page":"1123-1135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment"],"prefix":"10.1007","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5429-2008","authenticated-orcid":false,"given":"Clemens P. J. G.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Rachow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Zomorodbakhsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Foller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Rengsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"issue":"1","key":"3675_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12906-018-2150-8","volume":"18","author":"KA Abuelgasim","year":"2018","unstructured":"Abuelgasim KA, Alsharhan Y, Alenzi T, Alhazzani A, Ali YZ, Jazieh AR (2018) The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia. BMC Complement Altern Med 18(1):88. https:\/\/doi.org\/10.1186\/s12906-018-2150-8","journal-title":"BMC Complement Altern Med"},{"key":"3675_CR24","unstructured":"AbZ-Pharma GmbH (2016) Fachinformation Fols\u00e4ure AbZ 5 mg Tabletten. AbZ-Pharma GmbH. https:\/\/www.fachinfo.de\/api\/fachinfo\/pdf\/010497. (Accessed 15 Apr 2021)"},{"issue":"1","key":"3675_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/187231210790980435","volume":"4","author":"FI Al-Jenoobi","year":"2010","unstructured":"Al-Jenoobi FI, Al-Thukair AA, Abbas FA, Ansari MJ, Alkharfy KM, Al-Mohizea AM, Al-Suwayeh SA, Jamil S (2010) Effect of black seed on dextromethorphan O- and N-demethylation in human liver microsomes and healthy human subjects. Drug Metab Lett 4(1):51\u201355. https:\/\/doi.org\/10.2174\/187231210790980435","journal-title":"Drug Metab Lett"},{"issue":"1","key":"3675_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13318-014-0180-2","volume":"40","author":"FI Al-Jenoobi","year":"2015","unstructured":"Al-Jenoobi FI, Al-Thukair AA, Alam MA, Abbas FA, Al-Mohizea AM, Alkharfy KM, Al-Suwayeh SA (2015) Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects. Eur J Drug Metab Pharmacokinet 40(1):61\u201366. https:\/\/doi.org\/10.1007\/s13318-014-0180-2","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"3675_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41389-017-0025-3","volume":"7","author":"N Allocati","year":"2018","unstructured":"Allocati N, Masulli M, Di Ilio C, Federici L (2018) Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases. Oncogenesis 7(1):8. https:\/\/doi.org\/10.1038\/s41389-017-0025-3","journal-title":"Oncogenesis"},{"issue":"1","key":"3675_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12906-016-1372-x","volume":"16","author":"SM Alsanad","year":"2016","unstructured":"Alsanad SM, Howard RL, Williamson EM (2016) An assessment of the impact of herb-drug combinations used by cancer patients. BMC Complement Altern Med 16(1):393. https:\/\/doi.org\/10.1186\/s12906-016-1372-x","journal-title":"BMC Complement Altern Med"},{"issue":"4","key":"3675_CR6","first-page":"1029","volume":"27","author":"A Angelini","year":"2013","unstructured":"Angelini A, Conti P, Ciofani G, Cuccurullo F, Di Ilio C (2013) Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA\/Dx-5): implications on cancer therapy. J Biol Regul Homeost Agents 27(4):1029\u20131037","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"3675_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpainsymman.2006.03.013","volume":"32","author":"AA Argyriou","year":"2006","unstructured":"Argyriou AA, Chroni E, Koutras A, Iconomou G, Papapetropoulos S, Polychronopoulos P, Kalofonos HP (2006) Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. J Pain Symptom Manag 32(3):237\u2013244. https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.03.013","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"3675_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00774-005-0678-4","volume":"24","author":"GP Arumugam","year":"2006","unstructured":"Arumugam GP, Sundravel S, Shanthi P, Sachdanandam P (2006) Tamoxifen flare hypercalcemia: an additional support for gallium nitrate usage. J Bone Miner Metab 24(3):243\u2013247. https:\/\/doi.org\/10.1007\/s00774-005-0678-4","journal-title":"J Bone Miner Metab"},{"issue":"8","key":"3675_CR9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/annonc\/mdp324","volume":"20","author":"Z Baretta","year":"2009","unstructured":"Baretta Z, Ghiotto C, Marino D, Jirillo A (2009) Aloe-induced hypokalemia in a patient with breast cancer during chemotherapy. Ann Oncol 20(8):1445\u20131446. https:\/\/doi.org\/10.1093\/annonc\/mdp324","journal-title":"Ann Oncol"},{"issue":"15","key":"3675_CR10","doi-asserted-by":"publisher","first-page":"24401","DOI":"10.18632\/oncotarget.14224","volume":"8","author":"M Berretta","year":"2017","unstructured":"Berretta M, Della Pepa C, Tralongo P, Fulvi A, Martellotta F, Lleshi A, Nasti G, Fisichella R, Romano C, De Divitiis C, Taibi R, Fiorica F, Di Francia R, Di Mari A, Del Pup L, Crispo A, De Paoli P, Santorelli A, Quagliariello V, Iaffaioli RV, Tirelli U, Facchini G (2017) Use of complementary and alternative medicine (CAM) in cancer patients: an Italian multicenter survey. Oncotarget 8(15):24401\u201324414. https:\/\/doi.org\/10.18632\/oncotarget.14224","journal-title":"Oncotarget"},{"issue":"5","key":"3675_CR11","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/cncr.20484","volume":"101","author":"RF Branda","year":"2004","unstructured":"Branda RF, Naud SJ, Brooks EM, Chen Z, Muss H (2004) Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy-induced mucositis and neutropenia. Cancer 101(5):1058\u20131064. https:\/\/doi.org\/10.1002\/cncr.20484","journal-title":"Cancer"},{"key":"3675_CR12","doi-asserted-by":"publisher","first-page":"736431","DOI":"10.1155\/2015\/736431","volume":"2015","author":"H-J Cho","year":"2015","unstructured":"Cho H-J, Yoon I-S (2015) Pharmacokinetic interactions of herbs with cytochrome P450 and P-glycoprotein. Evid Based Complement Alternat Med 2015:736431. https:\/\/doi.org\/10.1155\/2015\/736431","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"3675_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/bdd.644","volume":"30","author":"JH Chung","year":"2009","unstructured":"Chung JH, Choi DH, Choi JS (2009) Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos 30(2):90\u201393. https:\/\/doi.org\/10.1002\/bdd.644","journal-title":"Biopharm Drug Dispos"},{"issue":"15","key":"3675_CR14","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1158\/1078-0432.Ccr-06-0388","volume":"12","author":"MC Cox","year":"2006","unstructured":"Cox MC, Low J, Lee J, Walshe J, Denduluri N, Berman A, Permenter MG, Petros WP, Price DK, Figg WD, Sparreboom A, Swain SM (2006) Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel. Clin Cancer Res 12(15):4636\u20134640. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-0388","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3675_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ptr.3564","volume":"26","author":"A Djuv","year":"2012","unstructured":"Djuv A, Nilsen OG (2012) Aloe vera juice: IC50 and dual mechanistic inhibition of CYP3A4 and CYP2D6. Phytother Res 26(3):445\u2013451. https:\/\/doi.org\/10.1002\/ptr.3564","journal-title":"Phytother Res"},{"issue":"2","key":"3675_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/cpt.1811","volume":"108","author":"SK Eagles","year":"2020","unstructured":"Eagles SK, Gross AS, McLachlan AJ (2020) The effects of cruciferous vegetable-enriched diets on drug metabolism: a systematic review and meta-analysis of dietary intervention trials in humans. Clin Pharmacol Ther 108(2):212\u2013227. https:\/\/doi.org\/10.1002\/cpt.1811","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"3675_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/ptr.2750","volume":"23","author":"S Engdal","year":"2009","unstructured":"Engdal S, Nilsen OG (2009) In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients. Phytother Res 23(7):906\u2013912. https:\/\/doi.org\/10.1002\/ptr.2750","journal-title":"Phytother Res"},{"issue":"1","key":"3675_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1534735408330202","volume":"8","author":"S Engdal","year":"2009","unstructured":"Engdal S, Klepp O, Nilsen OG (2009) Identification and exploration of herb-drug combinations used by cancer patients. Integr Cancer Ther 8(1):29\u201336. https:\/\/doi.org\/10.1177\/1534735408330202","journal-title":"Integr Cancer Ther"},{"issue":"5","key":"3675_CR19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1582-4934.2007.00089.x","volume":"11","author":"AJ Fahey","year":"2007","unstructured":"Fahey AJ, Adrian Robins R, Constantinescu CS (2007) Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells. J Cell Mol Med 11(5):1129\u20131137. https:\/\/doi.org\/10.1111\/j.1582-4934.2007.00089.x","journal-title":"J Cell Mol Med"},{"issue":"40","key":"3675_CR20","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.2174\/1381612825666190116124233","volume":"24","author":"PMP Ferreira","year":"2018","unstructured":"Ferreira PMP, Rodrigues L, de Alencar Carnib LP, de Lima Sousa PV, Nolasco Lugo LM, Nunes NMF, Do Nascimento Silva J, Da Silva AL, de Mac\u00eado Gon\u00e7alves Frota K  (2018) Cruciferous vegetables as antioxidative, chemopreventive and antineoplasic functional foods: preclinical and clinical evidences of sulforaphane against prostate cancers. Curr Pharm Des 24(40):4779\u20134793. https:\/\/doi.org\/10.2174\/1381612825666190116124233","journal-title":"Curr Pharm Des"},{"issue":"3","key":"3675_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00432-018-2587-7","volume":"144","author":"R Firkins","year":"2018","unstructured":"Firkins R, Eisfeld H, Keinki C, Buentzel J, Hochhaus A, Schmidt T, Huebner J (2018) The use of complementary and alternative medicine by patients in routine care and the risk of interactions. J Cancer Res Clin Oncol 144(3):551\u2013557. https:\/\/doi.org\/10.1007\/s00432-018-2587-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"3675_CR22","unstructured":"Foster BC, Foster MS, Vandenhoek S, Krantis A, Budzinski JW, Arnason JT, Gallicano KD, Choudri S (2001) An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharm Sci 4(2):176\u2013184. https:\/\/sites.ualberta.ca\/~csps\/JPPS4(2)\/B.Foster\/Garlic.pdf. (Accessed 15 Apr 2021)"},{"issue":"4","key":"3675_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/ijms17040537","volume":"17","author":"M Garc\u00eda-Cort\u00e9s","year":"2016","unstructured":"Garc\u00eda-Cort\u00e9s M, Robles-D\u00edaz M, Ortega-Alonso A, Medina-Caliz I, Andrade RJ (2016) Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics. Int J Mol Sci 17(4):537. https:\/\/doi.org\/10.3390\/ijms17040537","journal-title":"Int J Mol Sci"},{"issue":"23","key":"3675_CR26","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1182\/blood-2008-07-171389","volume":"113","author":"EB Golden","year":"2009","unstructured":"Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, Chen TC, Sch\u00f6nthal AH (2009) Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 113(23):5927\u20135937. https:\/\/doi.org\/10.1182\/blood-2008-07-171389","journal-title":"Blood"},{"issue":"2","key":"3675_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/10590501.2016.1166826","volume":"34","author":"X Guo","year":"2016","unstructured":"Guo X, Mei N (2016) Aloe vera: a review of toxicity and adverse clinical effects. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 34(2):77\u201396. https:\/\/doi.org\/10.1080\/10590501.2016.1166826","journal-title":"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev"},{"issue":"5","key":"3675_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.clpt.2004.07.007","volume":"76","author":"BJ Gurley","year":"2004","unstructured":"Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Carrier J, Khan IA, Edwards DJ, Shah A (2004) In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: citrus aurantium, echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 76(5):428\u2013440. https:\/\/doi.org\/10.1016\/j.clpt.2004.07.007","journal-title":"Clin Pharmacol Ther"},{"issue":"19","key":"3675_CR29","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.1158\/0008-5472.Can-08-1490","volume":"68","author":"ML Heaney","year":"2008","unstructured":"Heaney ML, Gardner JR, Karasavvas N, Golde DW, Scheinberg DA, Smith EA, O\u2019Connor OA (2008) Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res 68(19):8031\u20138038. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-1490","journal-title":"Cancer Res"},{"key":"3675_CR25","unstructured":"HEUMANN PHARMA GmbH & Co. Generica KG (2015) Fachinformation Fols\u00e4ure Heumann 5 mg Tabletten. HEUMANN PHARMA GmbH & Co. Generica KG. https:\/\/www.fachinfo.de\/api\/fachinfo\/pdf\/000307. (Accessed 19 Feb 2021)"},{"issue":"3","key":"3675_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3797\/scipharm.1002-11","volume":"78","author":"BE Ho","year":"2010","unstructured":"Ho BE, Shen DD, McCune JS, Bui T, Risler L, Yang Z, Ho RJ (2010) Effects of garlic on cytochromes P450 2C9- and 3A4-mediated drug metabolism in human hepatocytes. Sci Pharm 78(3):473\u2013481. https:\/\/doi.org\/10.3797\/scipharm.1002-11","journal-title":"Sci Pharm"},{"issue":"3","key":"3675_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/1534735411423920","volume":"11","author":"M Horneber","year":"2012","unstructured":"Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11(3):187\u2013203. https:\/\/doi.org\/10.1177\/1534735411423920","journal-title":"Integr Cancer Ther"},{"key":"3675_CR32","volume-title":"Komplement\u00e4re Onkologie: supportive Ma\u00dfnahmen und evidenzbasierte Empfehlungen","author":"J Huebner","year":"2012","unstructured":"Huebner J (2012) Komplement\u00e4re Onkologie: supportive Ma\u00dfnahmen und evidenzbasierte Empfehlungen, vol 2. Schattauer"},{"issue":"1","key":"3675_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000360381","volume":"9","author":"J Huebner","year":"2014","unstructured":"Huebner J, Muenstedt K, Prott FJ, Stoll C, Micke O, Buentzel J, Muecke R, Senf B (2014) Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care (Basel) 9(1):60\u201363. https:\/\/doi.org\/10.1159\/000360381","journal-title":"Breast Care (basel)"},{"key":"3675_CR34","unstructured":"JANSSEN-CILAG INTERNATIONAL NV (2019) Fachinformation VELCADE\u00ae 3.5 mg Pulver. Janssen-Cilag International NV. https:\/\/www.fachinfo.de\/api\/fachinfo\/pdf\/008387. (Accessed 15 Apr 2021)"},{"issue":"1\u20133","key":"3675_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0300-483x(00)00280-8","volume":"155","author":"SS Joshi","year":"2000","unstructured":"Joshi SS, Kuszynski CA, Bagchi M, Bagchi D (2000) Chemopreventive effects of grape seed proanthocyanidin extract on Chang liver cells. Toxicology 155(1\u20133):83\u201390. https:\/\/doi.org\/10.1016\/s0300-483x(00)00280-8","journal-title":"Toxicology"},{"issue":"1","key":"3675_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/ajcn\/nqy223","volume":"109","author":"AY Jung","year":"2019","unstructured":"Jung AY, Cai X, Thoene K, Obi N, Jaskulski S, Behrens S, Flesch-Janys D, Chang-Claude J (2019) Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy. Am J Clin Nutr 109(1):69\u201378. https:\/\/doi.org\/10.1093\/ajcn\/nqy223","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"3675_CR37","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/sj.bjp.0702803","volume":"128","author":"BY Kang","year":"1999","unstructured":"Kang BY, Song YJ, Kim KM, Choe YK, Hwang SY, Kim TS (1999) Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol 128(2):380\u2013384. https:\/\/doi.org\/10.1038\/sj.bjp.0702803","journal-title":"Br J Pharmacol"},{"issue":"11","key":"3675_CR38","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.clinthera.2005.11.004","volume":"27","author":"J Kennedy","year":"2005","unstructured":"Kennedy J (2005) Herb and supplement use in the US adult population. Clin Ther 27(11):1847\u20131858. https:\/\/doi.org\/10.1016\/j.clinthera.2005.11.004","journal-title":"Clin Therapeutics"},{"issue":"12","key":"3675_CR39","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1691\/ph.2012.2595","volume":"67","author":"IS Kim","year":"2012","unstructured":"Kim IS, Kim SY, Yoo HH (2012) Effects of an aqueous-ethanolic extract of ginger on cytochrome P450 enzyme-mediated drug metabolism. Pharmazie 67(12):1007\u20131009. https:\/\/doi.org\/10.1691\/ph.2012.2595","journal-title":"Pharmazie"},{"issue":"12","key":"3675_CR40","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1248\/bpb.33.1977","volume":"33","author":"Y Kimura","year":"2010","unstructured":"Kimura Y, Ito H, Hatano T (2010) Effects of mace and nutmeg on human cytochrome P450 3A4 and 2C9 activity. Biol Pharm Bull 33(12):1977\u20131982. https:\/\/doi.org\/10.1248\/bpb.33.1977","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"3675_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/01.coc.0000209369.44100.25","volume":"29","author":"AH Lee","year":"2006","unstructured":"Lee AH, Ingraham SE, Kopp M, Foraida MI, Jazieh AR (2006) The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration Hospital. Am J Clin Oncol 29(2):178\u2013182. https:\/\/doi.org\/10.1097\/01.coc.0000209369.44100.25","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"3675_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1142\/s0192415x10008068","volume":"38","author":"J Li","year":"2010","unstructured":"Li J, Liu H, Ramachandran S, Waypa GB, Yin JJ, Li CQ, Han M, Huang HH, Sillard WW, Vanden Hoek TL, Shao ZH (2010) Grape seed proanthocyanidins ameliorate doxorubicin-induced cardiotoxicity. Am J Chin Med 38(3):569\u2013584. https:\/\/doi.org\/10.1142\/s0192415x10008068","journal-title":"Am J Chin Med"},{"issue":"5","key":"3675_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12032-016-0764-6","volume":"33","author":"C Loquai","year":"2016","unstructured":"Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler K, Kurschat P, Meiss F, Stein A, Nashan D, Micke O, Muecke R, Muenstedt K, Stoll C, Schmidtmann I, Huebner J (2016) Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma. Med Oncol 33(5):52. https:\/\/doi.org\/10.1007\/s12032-016-0764-6","journal-title":"Med Oncol"},{"issue":"3","key":"3675_CR44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/CMR.0000000000000339","volume":"27","author":"C Loquai","year":"2017","unstructured":"Loquai C, Schmidtmann I, Garzarolli M, Kaatz M, Kaehler K, Kurschat P, Meiss F, Micke O, Muecke R, Muenstedt K, Nashan D, Stein A, Stoll C, Dechent D, Huebner J (2017) Interactions from complementary and alternative medicine in patients with melanoma. Melanoma Res 27(3):238\u2013242. https:\/\/doi.org\/10.1097\/CMR.0000000000000339","journal-title":"Melanoma Res"},{"issue":"2","key":"3675_CR45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/toxsci\/kfj031","volume":"89","author":"Y Lu","year":"2006","unstructured":"Lu Y, Cederbaum AI (2006) Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol Sci 89(2):515\u2013523. https:\/\/doi.org\/10.1093\/toxsci\/kfj031","journal-title":"Toxicol Sci"},{"issue":"5","key":"3675_CR46","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/bf02820805","volume":"43","author":"EL Lund","year":"1998","unstructured":"Lund EL, Quistorff B, Spang-Thomsen M, Kristjansen PE (1998) Effect of radiation therapy on small-cell lung cancer is reduced by ubiquinone intake. Folia Microbiol 43(5):505\u2013506. https:\/\/doi.org\/10.1007\/bf02820805","journal-title":"Folia Microbiol"},{"key":"3675_CR47","unstructured":"Mach CM, Fugii H, Wakame K, Smith J (2008) Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents. J Soc Integr Oncol 6(3):105\u2013109. http:\/\/ahccpublishedresearch.com\/articles\/wp-content\/uploads\/2016\/07\/IV.K.-AHCC-2008-Mach-In-Vitro.pdf. (Accessed 15 Apr 2021)"},{"issue":"2","key":"3675_CR48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/s0009-9236(03)00148-6","volume":"74","author":"JS Markowitz","year":"2003","unstructured":"Markowitz JS, Devane CL, Chavin KD, Taylor RM, Ruan Y, Donovan JL (2003) Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin Pharmacol Ther 74(2):170\u2013177. https:\/\/doi.org\/10.1016\/s0009-9236(03)00148-6","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3675_CR49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00228-008-0610-7","volume":"65","author":"G Mazzanti","year":"2009","unstructured":"Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, Mastrangelo S (2009) Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 65(4):331\u2013341. https:\/\/doi.org\/10.1007\/s00228-008-0610-7","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"3675_CR50","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s00520-004-0598-1","volume":"12","author":"JS McCune","year":"2004","unstructured":"McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK (2004) Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 12(6):454\u2013462. https:\/\/doi.org\/10.1007\/s00520-004-0598-1","journal-title":"Support Care Cancer"},{"issue":"1","key":"3675_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.eujim.2009.02.001","volume":"1","author":"O Micke","year":"2009","unstructured":"Micke O, Bruns F, Glatzel M, Sch\u00f6nekaes K, Micke P, M\u00fccke R, B\u00fcntzel J (2009) Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med 1(1):19\u201325. https:\/\/doi.org\/10.1016\/j.eujim.2009.02.001","journal-title":"Eur J Integrative Med"},{"issue":"4","key":"3675_CR52","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/annonc\/mdi110","volume":"16","author":"A Molassiotis","year":"2005","unstructured":"Molassiotis A, Fern\u00e1ndez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM-A, Platin N, Kearney N, Patiraki E (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16(4):655\u2013663. https:\/\/doi.org\/10.1093\/annonc\/mdi110","journal-title":"Ann Oncol"},{"issue":"3","key":"3675_CR53","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.bbrc.2004.12.081","volume":"327","author":"T Nabekura","year":"2005","unstructured":"Nabekura T, Kamiyama S, Kitagawa S (2005) Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem Biophys Res Commun 327(3):866\u2013870. https:\/\/doi.org\/10.1016\/j.bbrc.2004.12.081","journal-title":"Biochem Biophys Res Commun"},{"issue":"22","key":"3675_CR54","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.1002\/cncr.26164","volume":"117","author":"A Naing","year":"2011","unstructured":"Naing A, Stephen SK, Frenkel M, Chandhasin C, Hong DS, Lei X, Falchook G, Wheler JJ, Fu S, Kurzrock R (2011) Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience. Cancer 117(22):5142\u20135150. https:\/\/doi.org\/10.1002\/cncr.26164","journal-title":"Cancer"},{"key":"3675_CR55","unstructured":"NCCIH (2018) Complementary, alternative, or integrative health: what\u2019s in a name? National Center for Complementary and Integrative Health (NCCIH). https:\/\/www.nccih.nih.gov\/health\/complementary-alternative-or-integrative-health-whats-in-a-name. (Accessed 15 Apr 2021)"},{"key":"3675_CR56","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.chroma.2016.08.069","volume":"1465","author":"S Nestora","year":"2016","unstructured":"Nestora S, Merlier F, Prost E, Haupt K, Rossi C, Tse Sum Bui B (2016) Solid-phase extraction of betanin and isobetanin from beetroot extracts using a dipicolinic acid molecularly imprinted polymer. J Chromatogr A 1465:47\u201354. https:\/\/doi.org\/10.1016\/j.chroma.2016.08.069","journal-title":"J Chromatogr A"},{"issue":"5","key":"3675_CR57","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/jco.2003.05.139","volume":"21","author":"A Pace","year":"2003","unstructured":"Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B, Cognetti F, Bove L (2003) Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 21(5):927\u2013931. https:\/\/doi.org\/10.1200\/jco.2003.05.139","journal-title":"J Clin Oncol"},{"issue":"4","key":"3675_CR58","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1081\/iph-100108599","volume":"23","author":"HO Pae","year":"2001","unstructured":"Pae HO, Oh GS, Seo WG, Shin MK, Hong SG, Lee HS, Chung HT (2001) Mistletoe lectin synergizes with paclitaxel in human SK-hep1 hepatocarcinoma cells. Immunopharmacol Immunotoxicol 23(4):531\u2013540. https:\/\/doi.org\/10.1081\/iph-100108599","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"9","key":"3675_CR59","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/leu.2009.83","volume":"23","author":"G Perrone","year":"2009","unstructured":"Perrone G, Hideshima T, Ikeda H, Okawa Y, Calabrese E, Gorgun G, Santo L, Cirstea D, Raje N, Chauhan D, Baccarani M, Cavo M, Anderson KC (2009) Ascorbic acid inhibits antitumor activity of bortezomib in vivo. Leukemia 23(9):1679\u20131686. https:\/\/doi.org\/10.1038\/leu.2009.83","journal-title":"Leukemia"},{"issue":"48","key":"3675_CR60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3238\/PersOnko\/2017.12.01.04","volume":"114","author":"H Petri","year":"2017","unstructured":"Petri H (2017) Das Interaktionspotenzial konventioneller Zytostatika. Dtsch Arztebl 114(48):19\u201321. https:\/\/doi.org\/10.3238\/PersOnko\/2017.12.01.04","journal-title":"Dtsch Arztebl Internat"},{"issue":"2","key":"3675_CR61","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0165-1218(89)90163-8","volume":"224","author":"H Pohl","year":"1989","unstructured":"Pohl H, Reidy JA (1989) Vitamin C intake influences the bleomycin-induced chromosome damage assay: implications for detection of cancer susceptibility and chromosome breakage syndromes. Mutat Res 224(2):247\u2013252. https:\/\/doi.org\/10.1016\/0165-1218(89)90163-8","journal-title":"Mutat Res"},{"issue":"4","key":"3675_CR62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s0009-9120(00)00067-9","volume":"33","author":"O Portakal","year":"2000","unstructured":"Portakal O, Ozkaya O, Erden Inal M, Bozan B, Ko\u015fan M, Sayek I (2000) Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem 33(4):279\u2013284. https:\/\/doi.org\/10.1016\/s0009-9120(00)00067-9","journal-title":"Clin Biochem"},{"key":"3675_CR63","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2147\/DDDT.S74669","volume":"9","author":"J-X Qiu","year":"2015","unstructured":"Qiu J-X, Zhou Z-W, He Z-X, Zhang X, Zhou S-F, Zhu S (2015) Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies. Drug Des Devel Ther 9:841\u2013866. https:\/\/doi.org\/10.2147\/DDDT.S74669","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"3675_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00280-017-3358-x","volume":"80","author":"JCF Quintanilha","year":"2017","unstructured":"Quintanilha JCF, de Sousa VM, Visacri MB, Amaral LS, Santos RMM, Zambrano T, Salazar LA, Moriel P (2017) Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity. Cancer Chemother Pharmacol 80(2):223\u2013233. https:\/\/doi.org\/10.1007\/s00280-017-3358-x","journal-title":"Cancer Chemother Pharmacol"},{"issue":"13","key":"3675_CR65","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1200\/jco.2000.18.13.2505","volume":"18","author":"MA Richardson","year":"2000","unstructured":"Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary\/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18(13):2505\u20132514. https:\/\/doi.org\/10.1200\/jco.2000.18.13.2505","journal-title":"J Clin Oncol"},{"issue":"2","key":"3675_CR66","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jaad.2005.08.031","volume":"54","author":"L Rusciani","year":"2006","unstructured":"Rusciani L, Proietti I, Rusciani A, Paradisi A, Sbordoni G, Alfano C, Panunzi S, De Gaetano A, Lippa S (2006) Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol 54(2):234\u2013241. https:\/\/doi.org\/10.1016\/j.jaad.2005.08.031","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3675_CR67","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/1091581813503887","volume":"32","author":"S Savranoglu","year":"2013","unstructured":"Savranoglu S, Tumer TB (2013) Inhibitory effects of spirulina platensis on carcinogen-activating cytochrome P450 isozymes and potential for drug interactions. Int J Toxicol 32(5):376\u2013384. https:\/\/doi.org\/10.1177\/1091581813503887","journal-title":"Int J Toxicol"},{"issue":"1","key":"3675_CR68","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12906-017-2028-1","volume":"17","author":"M Schink","year":"2017","unstructured":"Schink M, Dehus O (2017) Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities. BMC Complement Altern Med 17(1):521. https:\/\/doi.org\/10.1186\/s12906-017-2028-1","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"3675_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/b:Brea.0000020991.55659.59","volume":"85","author":"G Sharma","year":"2004","unstructured":"Sharma G, Tyagi AK, Singh RP, Chan DC, Agarwal R (2004) Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells. Breast Cancer Res Treat 85(1):1\u201312. https:\/\/doi.org\/10.1023\/b:Brea.0000020991.55659.59","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"3675_CR70","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CAD.0b013e32832d6834","volume":"20","author":"SC Shin","year":"2009","unstructured":"Shin SC, Choi JS (2009) Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Anticancer Drugs 20(7):584\u2013588. https:\/\/doi.org\/10.1097\/CAD.0b013e32832d6834","journal-title":"Anticancer Drugs"},{"key":"3675_CR71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nutres.2020.01.005","volume":"75","author":"D Skyvalidas","year":"2020","unstructured":"Skyvalidas D, Mavropoulos A, Tsiogkas S, Dardiotis E, Liaskos C, Mamuris Z, Roussaki-Schulze A, Sakkas LI, Zafiriou E, Bogdanos DP (2020) Curcumin mediates attenuation of pro-inflammatory interferon \u03b3 and interleukin 17 cytokine responses in psoriatic disease, strengthening its role as a dietary immunosuppressant. Nutr Res 75:95\u2013108. https:\/\/doi.org\/10.1016\/j.nutres.2020.01.005","journal-title":"Nutr Res"},{"key":"3675_CR72","unstructured":"Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ (2002) Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res 62(13):3868\u20133875. https:\/\/cancerres.aacrjournals.org\/content\/canres\/62\/13\/3868.full.pdf. (Accessed 15 Apr 2021)"},{"issue":"5","key":"3675_CR73","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12312-011-0671-x","volume":"26","author":"P Teichfischer","year":"2011","unstructured":"Teichfischer P, Muenstedt K (2011) Zur Definition der Komplement\u00e4r- und Alternativmedizin (CAM). Forum 26(5):16. https:\/\/doi.org\/10.1007\/s12312-011-0671-x","journal-title":"Forum"},{"issue":"21","key":"3675_CR74","doi-asserted-by":"publisher","first-page":"7800","DOI":"10.1158\/1078-0432.Ccr-05-1288","volume":"11","author":"NP van Erp","year":"2005","unstructured":"van Erp NP, Baker SD, Zhao M, Rudek MA, Guchelaar HJ, Nortier JW, Sparreboom A, Gelderblom H (2005) Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan. Clin Cancer Res 11(21):7800\u20137806. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-05-1288","journal-title":"Clin Cancer Res"},{"issue":"8","key":"3675_CR75","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1124\/dmd.108.020552","volume":"36","author":"LP Volak","year":"2008","unstructured":"Volak LP, Ghirmai S, Cashman JR, Court MH (2008) Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab Dispos 36(8):1594\u20131605. https:\/\/doi.org\/10.1124\/dmd.108.020552","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"3675_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1515\/dmdi.2009.24.1.17","volume":"24","author":"S Wanwimolruk","year":"2009","unstructured":"Wanwimolruk S, Wong K, Wanwimolruk P (2009) Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metabol Drug Interact 24(1):17\u201335. https:\/\/doi.org\/10.1515\/dmdi.2009.24.1.17","journal-title":"Drug Metabol Drug Interact"},{"key":"3675_CR77","doi-asserted-by":"publisher","unstructured":"Wei R, Hu Y, Xiong J (2019) Effect size reporting practices in applied linguistics research: a study of one major journal. SAGE open 9(2). https:\/\/doi.org\/10.1177\/2158244019850035","DOI":"10.1177\/2158244019850035"},{"issue":"2","key":"3675_CR78","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/sj.bjc.6601560","volume":"90","author":"U Werneke","year":"2004","unstructured":"Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D (2004) Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 90(2):408\u2013413. https:\/\/doi.org\/10.1038\/sj.bjc.6601560","journal-title":"Br J Cancer"},{"issue":"1","key":"3675_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07357909209032783","volume":"10","author":"PH Wiernik","year":"1992","unstructured":"Wiernik PH, Yeap B, Vogl SE, Kaplan BH, Comis RL, Falkson G, Davis TE, Fazzini E, Cheuvart B, Horton J (1992) Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group. Cancer Invest 10(1):1\u20139. https:\/\/doi.org\/10.3109\/07357909209032783","journal-title":"Cancer Invest"},{"issue":"1","key":"3675_CR80","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12906-019-2452-5","volume":"19","author":"K Wode","year":"2019","unstructured":"Wode K, Henriksson R, Sharp L, Stoltenberg A, H\u00f6k Nordberg J (2019) Cancer patients\u2019 use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med 19(1):62. https:\/\/doi.org\/10.1186\/s12906-019-2452-5","journal-title":"BMC Complement Altern Med"},{"key":"3675_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03625-3","author":"C Wolf","year":"2021","unstructured":"Wolf C, Rachow T, Ernst T, Hochhaus A, Zomorodbakhsch B, Foller S, Rengsberger M, Hartmann M, H\u00fcbner J (2021) Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-021-03625-3","journal-title":"J Cancer Res Clin Oncol"},{"key":"3675_CR82","unstructured":"Xu Y, Zhang Y, Zhou F, Zheng Y, Zhu X (2011) [Human pregnane X receptor-mediated transcriptional regulation of CYP3A4 by extracts of 7 traditional Chinese medicines]. Zhongguo Zhong Yao Za Zhi 36(11):1524\u20131527. https:\/\/pubmed.ncbi.nlm.nih.gov\/22779192\/. (Accessed 15 Apr 2021)"},{"issue":"3","key":"3675_CR83","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00432-012-1336-6","volume":"139","author":"T Zeller","year":"2013","unstructured":"Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E, Becker S, Serve H, Huebner J (2013) Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol 139(3):357\u2013365. https:\/\/doi.org\/10.1007\/s00432-012-1336-6","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03675-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03675-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03675-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T07:30:30Z","timestamp":1650353430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03675-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3675"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03675-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]},"assertion":[{"value":"22 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"A vote of approval for the study was obtained from the ethics committee of the Jena University Hospital (2019-1623_1-Bef).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all patients included in this study to participate and allowing an anonymous publication of data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}